Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$190.52 - $236.72 $178,707 - $222,043
938 New
938 $217,000
Q2 2023

Aug 10, 2023

SELL
$275.25 - $318.06 $9,083 - $10,495
-33 Reduced 4.45%
708 $201,000
Q4 2022

Feb 14, 2023

SELL
$252.44 - $306.72 $5,553 - $6,747
-22 Reduced 2.88%
741 $205,000
Q3 2022

Nov 14, 2022

BUY
$194.69 - $268.46 $148,548 - $204,834
763 New
763 $204,000
Q1 2022

May 10, 2022

SELL
$193.77 - $244.14 $185,631 - $233,886
-958 Closed
0 $0
Q4 2021

Feb 10, 2022

SELL
$223.92 - $287.77 $96,061 - $123,453
-429 Reduced 30.93%
958 $230,000
Q3 2021

Oct 08, 2021

BUY
$282.99 - $369.05 $2,829 - $3,690
10 Added 0.73%
1,387 $393,000
Q2 2021

Aug 06, 2021

BUY
$259.0 - $414.71 $12,950 - $20,735
50 Added 3.77%
1,377 $477,000
Q1 2021

Apr 28, 2021

BUY
$242.95 - $284.63 $24,537 - $28,747
101 Added 8.24%
1,327 $371,000
Q3 2020

Nov 09, 2020

SELL
$264.77 - $305.71 $5,295 - $6,114
-20 Reduced 1.61%
1,226 $348,000
Q2 2020

Aug 03, 2020

SELL
$258.66 - $342.55 $329,015 - $435,723
-1,272 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$268.85 - $341.04 $11,829 - $15,005
-44 Reduced 3.34%
1,272 $402,000
Q4 2019

Feb 13, 2020

SELL
$220.06 - $304.07 $20,245 - $27,974
-92 Reduced 6.53%
1,316 $390,000
Q3 2019

Nov 14, 2019

BUY
$217.44 - $243.88 $35,442 - $39,752
163 Added 13.09%
1,408 $328,000
Q2 2019

Aug 08, 2019

BUY
$219.29 - $241.72 $30,262 - $33,357
138 Added 12.47%
1,245 $291,000
Q1 2019

Apr 29, 2019

BUY
$216.71 - $338.96 $8,451 - $13,219
39 Added 3.65%
1,107 $262,000
Q4 2018

Feb 12, 2019

SELL
$278.5 - $352.75 $7,241 - $9,171
-26 Reduced 2.38%
1,068 $321,000
Q3 2018

Nov 14, 2018

BUY
$293.51 - $383.83 $5,870 - $7,676
20 Added 1.86%
1,094 $387,000
Q2 2018

Aug 13, 2018

BUY
$257.52 - $306.91 $16,223 - $19,335
63 Added 6.23%
1,074 $312,000
Q1 2018

Apr 16, 2018

BUY
$260.13 - $367.91 $34,597 - $48,932
133 Added 15.15%
1,011 $277,000
Q4 2017

Feb 09, 2018

BUY
$307.64 - $344.58 $22,457 - $25,154
73 Added 9.07%
878 $280,000
Q3 2017

Oct 27, 2017

BUY
$281.15 - $329.69 $226,325 - $265,400
805
805 $252,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Probity Advisors, Inc. Portfolio

Follow Probity Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Probity Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Probity Advisors, Inc. with notifications on news.